Table 2 Salt intake and related biochemical parameters.

From: Yellow pea-based pasta's impacts on the salt intake, glycemic parameters and oxidative stress in healthy individuals: a randomized clinical trial

 

Week 0

Week 4

p1

Change

p2

BDHQ dietary salt intake (g/day)

 Control

11.4

(2.21)

9.50

(2.62)

< 0.001***

− 1.94

(2.17)

0.27

 YPP

11.8

(3.69)

10.6

(3.93)

0.035*

− 1.15

(2.20)

Daily urine salt (g/day)

 Control

9.18

(3.16)

9.63

(2.71)

0.59

0.45

(3.66)

0.30

 YPP

9.52

(3.48)

8.75

(2.49)

0.36

− 0.77

(3.53)

Urine salt measured at the clinic (g/day)

 Control

8.05

(1.77)

8.78

(1.72)

0.036*

0.74

(1.46)

0.13

 YPP

7.67

(1.62)

7.39

(2.04)

0.63

− 0.29

(2.51)

Sensitivity to saltiness

 Control

55.1

(15.6)

49.7

(18.9)

0.26

− 5.40

(20.6)

0.96

 YPP

56.7

(16.9)

50.9

(16.4)

0.29

− 5.74

(23.0)

Aldosterone (pg/mL)

 Control

62.3

(37.5)

62.3

(54.4)

0.56

− 0.02

(38.5)

0.63

 YPP

104

(154)

108

(132)

0.61

3.86

(95.8)

Plasma renin activity (ng/mL/h)

 Control

1.12

(0.98)

1.53

(1.08)

0.14

0.41

(0.76)

0.12

 YPP

2.16

(2.31)

2.12

(1.76)

0.61

− 0.042

(0.98)

ACE1 (IU/L)

 Control

13.6

(3.62)

14.9

(4.30)

< 0.001***

1.35

(1.41)

0.65

 YPP

14.1

(3.85)

15.6

(4.03)

< 0.001***

1.54

(1.16)

ACE2 (pg/mL)

 Control

2519

(1423)

2220

(1451)

0.20

− 299

(1010)

0.28

 YPP

2152

(1225)

2014

(888)

0.36

− 138

(638)

  1. Data are presented as mean (SD). Daily urinary salt content was calculated using a self-monitoring device (KME-03). Urinary salt content measured at the clinic was calculated via spot urine collection. 1Within-group comparisons (Week 0 vs. Week 4) using paired-samples t-test or Wilcoxon signed-rank test. 2Group comparison of change using independent-samples t-test or Wilcoxon rank-sum test. *p < 0.05, **p < 0.01, ***p < 0.001. ACE, Angiotensin converting enzyme; YPP, Yellow pea pasta.
Back to article page